Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Miriam Post

Concepts (365)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
17
2026
604
1.640
Why?
Stillbirth
2
2024
83
1.530
Why?
Placenta
10
2024
794
1.470
Why?
Cystadenocarcinoma, Serous
8
2026
90
1.220
Why?
Uterine Neoplasms
6
2019
98
1.120
Why?
Carcinosarcoma
5
2018
23
1.040
Why?
Fetal Death
1
2023
59
0.790
Why?
Pathologists
3
2017
19
0.700
Why?
Clinical Competence
3
2022
1272
0.700
Why?
Tumor Microenvironment
5
2026
747
0.690
Why?
Endometrial Neoplasms
6
2023
205
0.670
Why?
Education, Medical, Continuing
1
2022
130
0.660
Why?
Microfilament Proteins
1
2017
136
0.490
Why?
Hemangioma, Capillary
1
2015
14
0.440
Why?
Fetal Growth Retardation
3
2024
592
0.420
Why?
Autopsy
2
2024
96
0.400
Why?
Immunohistochemistry
9
2026
1712
0.390
Why?
Carrier Proteins
1
2017
728
0.390
Why?
Lymph Nodes
4
2018
511
0.390
Why?
Poly(ADP-ribose) Polymerase Inhibitors
3
2026
139
0.380
Why?
Fetus
3
2024
800
0.380
Why?
Pre-Eclampsia
2
2021
206
0.380
Why?
Biomarkers, Tumor
11
2026
1339
0.350
Why?
Female
57
2026
79499
0.350
Why?
Pathology
3
2017
21
0.340
Why?
Neoplasms, Cystic, Mucinous, and Serous
2
2026
27
0.320
Why?
Pregnancy
11
2024
7230
0.320
Why?
Drug Resistance, Neoplasm
4
2026
893
0.310
Why?
Humans
65
2026
146342
0.310
Why?
Adenocarcinoma, Mucinous
2
2022
76
0.300
Why?
Prognosis
11
2024
4351
0.300
Why?
Osteoblastoma
1
2008
2
0.290
Why?
Prolactinoma
1
2008
13
0.290
Why?
Breast Neoplasms
5
2026
2418
0.280
Why?
Receptors, Estrogen
6
2026
406
0.280
Why?
Skull Base
1
2008
53
0.280
Why?
Skull Base Neoplasms
1
2008
30
0.280
Why?
Neoplasms, Multiple Primary
1
2008
57
0.270
Why?
Diagnosis, Differential
6
2024
1503
0.260
Why?
Cytomegalovirus
1
2009
172
0.260
Why?
Cell Line, Tumor
13
2026
3545
0.250
Why?
Lymphatic Vessels
2
2018
64
0.250
Why?
Peritoneal Neoplasms
3
2014
103
0.250
Why?
Uterus
3
2022
227
0.250
Why?
Fetal Diseases
1
2009
192
0.250
Why?
Professionalism
2
2017
27
0.250
Why?
Cytomegalovirus Infections
1
2009
206
0.250
Why?
Pituitary Neoplasms
1
2008
190
0.240
Why?
E1A-Associated p300 Protein
1
2026
15
0.240
Why?
Interleukin-6
3
2024
784
0.240
Why?
Receptors, Interleukin-8B
1
2026
29
0.240
Why?
Ketoglutaric Acids
1
2026
23
0.240
Why?
Gestational Age
4
2024
990
0.240
Why?
Neoplasm Recurrence, Local
4
2026
1160
0.230
Why?
Carnitine
1
2026
91
0.230
Why?
Pregnancy Complications, Infectious
1
2009
438
0.200
Why?
Infant, Newborn
4
2024
6460
0.200
Why?
Tryptophan Oxygenase
1
2024
33
0.200
Why?
Chorionic Villi
1
2024
24
0.200
Why?
DNA Repair
1
2026
255
0.200
Why?
Uterine Cervical Neoplasms
2
2021
269
0.200
Why?
Umbilical Arteries
1
2024
51
0.200
Why?
Neoplasm Invasiveness
6
2018
504
0.190
Why?
Gene Expression Regulation, Neoplastic
4
2024
1432
0.190
Why?
Middle Aged
23
2026
36619
0.190
Why?
Hypertension, Pulmonary
1
2015
1957
0.190
Why?
Education, Medical, Graduate
4
2017
568
0.190
Why?
Hypertension, Pregnancy-Induced
1
2024
69
0.190
Why?
Choriocarcinoma
1
2022
9
0.190
Why?
Endodermal Sinus Tumor
1
2022
10
0.190
Why?
Fallopian Tubes
1
2022
33
0.190
Why?
Histones
2
2026
670
0.190
Why?
Carcinoma, Endometrioid
2
2022
49
0.190
Why?
Dendritic Cell Sarcoma, Follicular
1
2022
4
0.180
Why?
In Situ Hybridization, Fluorescence
1
2023
334
0.180
Why?
Carcinoma, Squamous Cell
2
2021
628
0.180
Why?
Neoplasm Staging
5
2019
1488
0.180
Why?
Tertiary Care Centers
1
2023
196
0.180
Why?
Internship and Residency
3
2017
1281
0.180
Why?
Lung Neoplasms
2
2015
2675
0.180
Why?
Specialty Boards
1
2022
42
0.180
Why?
Carcinoma, Adenosquamous
1
2021
9
0.170
Why?
Neoplasm Grading
4
2026
313
0.170
Why?
Hysterectomy
3
2022
139
0.170
Why?
Neoplasms, Germ Cell and Embryonal
1
2022
76
0.170
Why?
Granulosa Cells
1
2021
37
0.170
Why?
Cisplatin
3
2026
347
0.170
Why?
Premature Birth
2
2024
390
0.170
Why?
beta Catenin
2
2023
250
0.170
Why?
Antigens, CD
2
2015
560
0.160
Why?
Ovarian Follicle
1
2021
78
0.160
Why?
Ovary
1
2022
236
0.160
Why?
Certification
1
2022
118
0.160
Why?
Decidua
2
2012
21
0.160
Why?
Programmed Cell Death 1 Receptor
1
2022
268
0.160
Why?
Adult
23
2026
41087
0.160
Why?
Lymphocytes, Tumor-Infiltrating
1
2021
156
0.160
Why?
High-Throughput Nucleotide Sequencing
1
2023
539
0.150
Why?
Lymphatic Metastasis
5
2026
335
0.150
Why?
Neovascularization, Physiologic
1
2021
189
0.150
Why?
Xenograft Model Antitumor Assays
6
2026
930
0.150
Why?
Leiomyosarcoma
1
2019
30
0.150
Why?
Histocompatibility Antigens
1
2019
102
0.140
Why?
Phthalazines
1
2019
64
0.140
Why?
Endometrium
2
2022
64
0.140
Why?
Leiomyoma
1
2019
62
0.140
Why?
Estrogens
2
2012
364
0.140
Why?
Artificial Intelligence
1
2024
389
0.140
Why?
Up-Regulation
1
2021
841
0.140
Why?
Gene Expression Profiling
4
2019
1792
0.140
Why?
Adenocarcinoma, Clear Cell
1
2018
14
0.140
Why?
Diverticulum
1
2018
14
0.140
Why?
Uterine Diseases
1
2018
18
0.140
Why?
Antineoplastic Agents
2
2023
2219
0.130
Why?
Histone-Lysine N-Methyltransferase
1
2019
141
0.130
Why?
Adenocarcinoma
2
2015
927
0.130
Why?
Fetal Blood
2
2021
325
0.130
Why?
Piperazines
1
2019
368
0.120
Why?
Blood Vessels
1
2018
164
0.120
Why?
Cytoreduction Surgical Procedures
1
2017
69
0.120
Why?
Extracellular Matrix
1
2021
565
0.120
Why?
B7-H1 Antigen
3
2024
245
0.120
Why?
Aged
14
2026
26432
0.120
Why?
Receptors, Progesterone
3
2015
242
0.120
Why?
Cell Proliferation
5
2015
2502
0.120
Why?
Medroxyprogesterone Acetate
1
2015
33
0.120
Why?
Retinopathy of Prematurity
1
2018
183
0.120
Why?
Employment
1
2017
180
0.110
Why?
Keratin-5
1
2015
43
0.110
Why?
Pelvic Neoplasms
1
2015
24
0.110
Why?
Neoplasms, Glandular and Epithelial
1
2015
52
0.110
Why?
Job Satisfaction
1
2017
236
0.110
Why?
Skin Neoplasms
2
2012
806
0.110
Why?
Lymphangioleiomyomatosis
1
2015
37
0.110
Why?
Chemotherapy, Adjuvant
3
2026
429
0.110
Why?
Incidental Findings
1
2015
81
0.110
Why?
Tuberous Sclerosis
1
2015
56
0.110
Why?
Endothelial Cells
1
2021
876
0.110
Why?
Mice
10
2026
18297
0.110
Why?
Mutation
2
2023
4093
0.110
Why?
Mesothelioma, Cystic
1
2014
1
0.110
Why?
Oxidative Stress
1
2021
1369
0.100
Why?
Tumor Necrosis Factor-alpha
2
2021
1224
0.100
Why?
Chest Pain
1
2015
100
0.100
Why?
Antineoplastic Agents, Hormonal
1
2015
196
0.100
Why?
Tumor Suppressor Protein p53
3
2024
530
0.100
Why?
Carcinoma
1
2016
225
0.100
Why?
Chorioamnionitis
1
2014
50
0.100
Why?
Capillaries
1
2015
123
0.100
Why?
Cough
1
2015
123
0.100
Why?
Glycoproteins
1
2015
356
0.100
Why?
Fertility Preservation
1
2014
57
0.100
Why?
Accreditation
1
2014
100
0.100
Why?
Animals
13
2026
38107
0.100
Why?
Interleukin-8
1
2014
268
0.100
Why?
Sarcoma
1
2016
209
0.100
Why?
Adenomyosis
1
2013
7
0.100
Why?
DNA Damage
2
2026
439
0.100
Why?
Educational Measurement
1
2016
331
0.100
Why?
Survival Rate
4
2018
2092
0.090
Why?
Robotics
1
2014
89
0.090
Why?
Gestational Trophoblastic Disease
1
2012
6
0.090
Why?
Dyspnea
1
2015
251
0.090
Why?
Infertility
1
2013
62
0.090
Why?
Luteinizing Hormone
1
2013
206
0.090
Why?
Lectins
1
2012
44
0.090
Why?
Menstrual Cycle
1
2013
145
0.090
Why?
Antigens, Differentiation, Myelomonocytic
1
2012
66
0.090
Why?
Fatigue
1
2015
363
0.090
Why?
Neural Stem Cells
1
2014
167
0.090
Why?
Interleukin-1beta
1
2014
397
0.090
Why?
Disease Progression
4
2026
2867
0.090
Why?
Apoptosis
4
2015
2439
0.090
Why?
Carcinoma, Lobular
1
2012
59
0.090
Why?
Antibodies, Neoplasm
1
2012
34
0.090
Why?
Fallopian Tube Neoplasms
1
2011
20
0.090
Why?
Endometriosis
1
2012
58
0.090
Why?
Neoplastic Stem Cells
1
2015
403
0.090
Why?
Cicatrix
1
2012
72
0.090
Why?
Lymph Node Excision
3
2018
174
0.090
Why?
DNA Polymerase II
2
2023
35
0.090
Why?
Poly-ADP-Ribose Binding Proteins
2
2023
35
0.090
Why?
Retrospective Studies
9
2024
17438
0.080
Why?
Paclitaxel
1
2012
260
0.080
Why?
Nervous System Diseases
1
2014
288
0.080
Why?
Immunocompromised Host
1
2012
201
0.080
Why?
M Phase Cell Cycle Checkpoints
1
2011
23
0.080
Why?
Bridged-Ring Compounds
1
2011
31
0.080
Why?
Leptin
1
2012
248
0.080
Why?
Trophoblastic Neoplasms
1
2010
2
0.080
Why?
Carcinoma, Large Cell
1
2010
17
0.080
Why?
Neoplasms, Squamous Cell
1
2010
4
0.080
Why?
Diagnostic Errors
1
2012
178
0.080
Why?
Taxoids
1
2011
115
0.080
Why?
Skin Diseases
1
2012
144
0.080
Why?
Carcinoma, Neuroendocrine
1
2010
38
0.080
Why?
United States
4
2022
16136
0.080
Why?
Biological Evolution
1
2014
471
0.080
Why?
Cesarean Section
1
2012
230
0.080
Why?
Graft vs Host Disease
1
2012
283
0.080
Why?
Disease-Free Survival
2
2026
778
0.080
Why?
Peptides
1
2015
992
0.080
Why?
Biopsy
3
2022
1075
0.070
Why?
Tumor Burden
2
2026
326
0.070
Why?
Amniocentesis
1
2009
20
0.070
Why?
Africa, Eastern
1
2009
12
0.070
Why?
Genital Neoplasms, Female
1
2010
100
0.070
Why?
Inflammation
2
2018
2919
0.070
Why?
Fever of Unknown Origin
1
2009
13
0.070
Why?
Attitude of Health Personnel
1
2017
1219
0.070
Why?
Infarction
1
2008
9
0.070
Why?
Prolactin
1
2008
88
0.070
Why?
Cell Survival
2
2026
1105
0.070
Why?
Blood Chemical Analysis
1
2008
109
0.070
Why?
Homeodomain Proteins
1
2012
525
0.070
Why?
Viremia
1
2009
158
0.070
Why?
Travel
1
2009
134
0.070
Why?
Headache
1
2008
150
0.070
Why?
Neoplasm Proteins
1
2010
444
0.060
Why?
Immunoglobulin M
1
2009
284
0.060
Why?
Models, Statistical
1
2011
669
0.060
Why?
Ultrasonography, Prenatal
1
2009
291
0.060
Why?
Radiotherapy, Adjuvant
2
2018
222
0.060
Why?
Hematopoietic Stem Cell Transplantation
1
2012
704
0.060
Why?
Acetyl Coenzyme A
1
2026
8
0.060
Why?
Case-Control Studies
3
2021
3647
0.060
Why?
Surveys and Questionnaires
2
2017
6073
0.060
Why?
Mixed Function Oxygenases
1
2026
43
0.060
Why?
Homologous Recombination
1
2026
38
0.060
Why?
Dioxygenases
1
2026
36
0.060
Why?
Macrophages
2
2024
1532
0.060
Why?
Poly (ADP-Ribose) Polymerase-1
1
2026
55
0.060
Why?
MicroRNAs
1
2012
699
0.060
Why?
Phenylurea Compounds
1
2026
122
0.060
Why?
Survival Analysis
2
2021
1378
0.060
Why?
Mice, Nude
3
2012
668
0.060
Why?
Acidosis
1
2026
105
0.060
Why?
Myeloid-Derived Suppressor Cells
1
2026
78
0.060
Why?
Acetylation
1
2026
262
0.060
Why?
Hydrogen-Ion Concentration
1
2026
534
0.050
Why?
Immunoglobulin G
1
2009
901
0.050
Why?
Cohort Studies
3
2024
6077
0.050
Why?
Aged, 80 and over
3
2024
8391
0.050
Why?
Follow-Up Studies
3
2018
5439
0.050
Why?
BRCA2 Protein
1
2024
69
0.050
Why?
Polycomb Repressive Complex 1
1
2024
65
0.050
Why?
Prospective Studies
3
2023
8123
0.050
Why?
Immunophenotyping
1
2024
324
0.050
Why?
DNA Mismatch Repair
1
2023
54
0.050
Why?
Ultrasonography, Doppler
1
2024
122
0.050
Why?
Kynurenine
1
2024
114
0.050
Why?
Activating Transcription Factor 6
1
2023
19
0.050
Why?
Neoadjuvant Therapy
1
2026
475
0.050
Why?
Transcription Factor AP-1
1
2023
76
0.050
Why?
Tryptophan
1
2024
184
0.050
Why?
Ultrasonography
2
2018
788
0.040
Why?
Brain
1
2014
2991
0.040
Why?
Lung
1
2015
4122
0.040
Why?
Eukaryotic Initiation Factor-2
1
2021
34
0.040
Why?
Mice, SCID
2
2012
360
0.040
Why?
Maternal Age
1
2021
129
0.040
Why?
Cervix Uteri
1
2021
50
0.040
Why?
Carcinogenesis
1
2022
226
0.040
Why?
Open Reading Frames
1
2021
130
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
1998
0.040
Why?
Ligands
1
2022
678
0.040
Why?
Neutrophils
1
2026
1133
0.040
Why?
Enzyme Inhibitors
1
2024
823
0.040
Why?
Cellular Microenvironment
1
2021
94
0.040
Why?
Magnetic Resonance Imaging
2
2013
3926
0.040
Why?
Cell Division
1
2021
736
0.040
Why?
Chitinase-3-Like Protein 1
1
2019
18
0.040
Why?
Estradiol
2
2013
517
0.040
Why?
Intramolecular Oxidoreductases
1
2019
64
0.040
Why?
Young Adult
4
2021
14330
0.040
Why?
Microsatellite Instability
1
2019
57
0.040
Why?
Cytoskeletal Proteins
1
2019
146
0.040
Why?
Pregnancy, Tubal
1
2018
5
0.030
Why?
Fetal Development
1
2021
297
0.030
Why?
Class I Phosphatidylinositol 3-Kinases
1
2019
111
0.030
Why?
Ovarian Cysts
1
2018
6
0.030
Why?
Immunity, Maternally-Acquired
1
2018
18
0.030
Why?
Protein Processing, Post-Translational
1
2021
487
0.030
Why?
Salpingectomy
1
2018
15
0.030
Why?
Protein Biosynthesis
1
2021
449
0.030
Why?
Predictive Value of Tests
2
2015
2113
0.030
Why?
Microtubule-Associated Proteins
1
2019
187
0.030
Why?
Tomography, X-Ray Computed
1
2008
2786
0.030
Why?
Frozen Sections
1
2018
23
0.030
Why?
PTEN Phosphohydrolase
1
2019
166
0.030
Why?
Pelvic Pain
1
2018
43
0.030
Why?
Abortion, Spontaneous
1
2018
120
0.030
Why?
Sequence Analysis, RNA
1
2019
441
0.030
Why?
Phosphorylation
1
2021
1724
0.030
Why?
Treatment Outcome
2
2026
11821
0.030
Why?
Cell Movement
1
2021
951
0.030
Why?
Mass Spectrometry
1
2019
729
0.030
Why?
Ifosfamide
1
2016
39
0.030
Why?
Risk Factors
3
2018
10921
0.030
Why?
AC133 Antigen
1
2015
20
0.030
Why?
Faculty
1
2017
152
0.030
Why?
Tissue Array Analysis
1
2015
49
0.030
Why?
Abortion, Induced
1
2018
112
0.030
Why?
Cell Line
1
2021
2814
0.030
Why?
Risk
1
2018
920
0.030
Why?
Cell Count
1
2015
315
0.030
Why?
RNA-Binding Proteins
1
2019
465
0.030
Why?
Cell Cycle Proteins
1
2019
630
0.030
Why?
Time Factors
1
2026
7109
0.030
Why?
Receptors, Androgen
1
2015
149
0.030
Why?
Transcriptome
1
2021
1068
0.030
Why?
Peritoneal Cavity
1
2014
30
0.030
Why?
Sensitivity and Specificity
1
2019
1998
0.030
Why?
T-Lymphocytes
1
2022
2012
0.030
Why?
Follicular Phase
1
2013
41
0.020
Why?
Fellowships and Scholarships
1
2017
355
0.020
Why?
Luteal Phase
1
2013
51
0.020
Why?
Hysteroscopy
1
2013
14
0.020
Why?
Primates
1
2014
133
0.020
Why?
Laparoscopy
1
2018
487
0.020
Why?
Organ Size
1
2014
465
0.020
Why?
Oocytes
1
2014
186
0.020
Why?
Cryopreservation
1
2014
115
0.020
Why?
RNA, Messenger
2
2012
2791
0.020
Why?
Vaginal Neoplasms
1
2012
20
0.020
Why?
Karyotyping
1
2012
106
0.020
Why?
Anoikis
1
2012
30
0.020
Why?
Membrane Proteins
1
2019
1130
0.020
Why?
Pilot Projects
1
2018
1888
0.020
Why?
Male
4
2017
73396
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2014
846
0.020
Why?
Transduction, Genetic
1
2012
129
0.020
Why?
Tamoxifen
1
2012
193
0.020
Why?
Protein Structure, Tertiary
1
2014
834
0.020
Why?
Mothers
1
2018
772
0.020
Why?
Antibody Specificity
1
2012
181
0.020
Why?
Transplantation, Heterologous
1
2012
165
0.020
Why?
Perioperative Period
1
2011
69
0.020
Why?
Tubulin
1
2012
124
0.020
Why?
Gynecologic Surgical Procedures
1
2011
68
0.020
Why?
Cell Adhesion
1
2012
447
0.020
Why?
Mice, Inbred NOD
1
2012
598
0.020
Why?
Selective Estrogen Receptor Modulators
1
2010
33
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2010
74
0.020
Why?
Cell Cycle Checkpoints
1
2011
97
0.020
Why?
Immunoenzyme Techniques
1
2010
197
0.020
Why?
Transfection
1
2012
916
0.020
Why?
Organ Specificity
1
2010
307
0.020
Why?
Biomarkers
1
2021
4340
0.020
Why?
Mitosis
1
2011
195
0.020
Why?
HeLa Cells
1
2011
636
0.020
Why?
Regression Analysis
1
2011
999
0.020
Why?
Adolescent
1
2008
22557
0.020
Why?
Microtubules
1
2011
226
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2010
752
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
974
0.020
Why?
Blotting, Western
1
2010
1177
0.020
Why?
Polymerase Chain Reaction
1
2010
1031
0.020
Why?
Cytokines
1
2014
2081
0.020
Why?
Chronic Disease
1
2012
1827
0.020
Why?
Cross-Sectional Studies
1
2018
5899
0.010
Why?
Leukemia, Myeloid, Acute
1
2012
702
0.010
Why?
Infant
1
2018
10114
0.010
Why?
Severity of Illness Index
1
2011
2921
0.010
Why?
Signal Transduction
1
2011
5246
0.010
Why?
Post's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)